THERACRYF PLC (TCF) — Investor Presentation

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Theracryf Plc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04948-1952-7403-a863-26ffdc7ac4d7 Created: 2026-08-28T16:51:18.256Z Duration: 1408.836 Channels: 1 00:00:01.520 -- 00:00:04.160 Good morning, and welcome to the FGen Pharma 00:00:04.160 -- 00:00:06.160 PLC Investor Presentation. 00:00:06.319 -- 00:00:08.559 Throughout this recorded meeting, investors will be in 00:00:08.559 -- 00:00:11.040 listen only mode. Given the acquisition and the 00:00:11.040 -- 00:00:13.599 respective fundraising are subject to approval at a 00:00:13.599 -- 00:00:16.015 general meeting for shareholders, there will be no 00:00:16.015 -- 00:00:18.175 q and a in today's session. Before we 00:00:18.175 -- 00:00:19.695 begin, I would like to submit the following 00:00:19.695 -- 00:00:20.415 poll. 00:00:20.655 -- 00:00:22.095 And I would now like to hand you 00:00:22.095 -- 00:00:25.134 over to CEO, doctor Hugh Jones. Good morning. 00:00:25.535 -- 00:00:27.855 Good morning, and thank you everybody for attending 00:00:28.420 -- 00:00:30.820 our investor meet presentation ahead of a book 00:00:30.820 -- 00:00:32.420 build exercise, 00:00:32.420 -- 00:00:34.180 which starts, immediately. 00:00:34.580 -- 00:00:35.620 We're here, 00:00:35.860 -- 00:00:38.420 at Evgen proposing to acquire a private UK 00:00:38.420 -- 00:00:40.660 company, The Corona Therapeutics Limited. 00:00:40.900 -- 00:00:42.820 We announced a placing yesterday, 00:00:42.820 -- 00:00:45.425 and this webinar is really about the accompanying 00:00:45.425 -- 00:00:49.185 retail offer that comes with that activity. With 00:00:49.185 -- 00:00:49.905 me here, 00:00:50.465 -- 00:00:53.425 is Tony Hynonen, our chief financial officer, and 00:00:53.425 -- 00:00:54.705 doctor Helen Cullman, 00:00:54.705 -- 00:00:57.090 our chief bus...